Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") confirmed it has submitted a non-binding proposal to the Management Board and Supervisory Board of Evotec SE ("Evotec") to acquire Evotec for ...
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.
The European Commission is asking biopharma and manufacturing companies about their reaction to Novo ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.
Nektar continues to make progress with rezpegaldesleukin, with results from phase 2 atopic dermatitis study expected in H1'25 ...
Artificial intelligence (AI) continues to drive the next wave of technological transformation, attracting investors seeking ...
Eli Lilly & Co. will set up a S$42 million ($31 million) digital health innovation hub in Singapore, expanding its research ...
The company, headquartered in the key swing state of Pennsylvania, has announced the creation of 330 jobs in a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback